Vector BioPharma
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $30M
Overview
Engineering advanced viral vectors to enable safer and more effective gene therapies for rare genetic diseases.
Rare DiseaseGenetics & GenomicsNeurology
Technology Platform
A vector discovery platform that uses protein engineering and screening to develop novel viral capsids with improved targeting, safety, and delivery efficiency for gene therapy.
Funding History
1Total raised:$30M
Venture$30M
Opportunities
Next-generation vectors are a critical bottleneck in gene therapy; successful technology could be leveraged across dozens of disease programs through partnerships.
Risk Factors
Technical risk of developing a vector that is meaningfully better than existing standards, and regulatory risk associated with novel delivery systems.
Competitive Landscape
Operates in the competitive vector engineering space, competing with well-funded startups and large gene therapy companies investing in internal vector R&D.